Related Experiment Videos
Risk factors for heterotopic ossification in spinal cord injury
S Lal1, B B Hamilton, A Heinemann
1Rehabilitation Institute of Chicago, IL 60611.
Archives of Physical Medicine and Rehabilitation
|May 1, 1989
Summary
Identifying risk factors for heterotopic ossification (HO) in spinal cord injury (SCI) patients is crucial. Age, lesion completeness, pressure sores, and spasticity significantly predict HO development in SCI.
Area of Science:
- Neurology
- Orthopedics
- Rehabilitation Medicine
Background:
- Heterotopic ossification (HO) is a common complication following spinal cord injury (SCI), affecting up to 53% of patients.
- Moderate to severe HO can significantly impair function and health in SCI patients.
- Current prophylactic treatments for HO in SCI are controversial, and risk factors from other conditions do not apply.
Purpose of the Study:
- To identify specific risk factors for heterotopic ossification (HO) in patients with spinal cord injury (SCI).
- To determine if specific demographic and medical variables can predict high-risk individuals for HO development after SCI.
Main Methods:
- Retrospective review of medical charts for 100 randomly selected SCI patients (50 with HO, 50 without HO).
- Analysis of 14 variables: 7 demographic (age, sex, race, lesion level, lesion completeness, injury cause, geographic locus) and 7 medical (bladder stones, fractures, pressure sores, deep vein thrombosis, pulmonary embolism, spasticity, urinary tract infections).
Main Results:
- Four variables were significantly associated with HO formation: age, completeness of the lesion, presence of pressure sores, and spasticity.
- These risk factors appear to be additive, with 92% of patients having HO when all four factors were present.
- No specific risk factors for HO in SCI were previously identified in the literature.
Conclusions:
- Age, lesion completeness, pressure sores, and spasticity are significant predictors of HO in SCI patients.
- These identified risk factors may help in stratifying SCI patients for HO risk.
- Further prospective studies are recommended to validate the predictive value of these factors in clinical practice.